Lataa...

Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel(®): A Case Report

The CLARINET study (ClinicalTrials.gov: NCT00353496) showed that somatostatin analogs are able to stabilize tumor growth in patients with intestinal and pancreatic neuroendocrine tumors (NETs). Here, we present a case of NET originating from the pancreatic tail that was treated with lanreotide Autog...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Oncol
Päätekijät: Lybaert, Willem, Van Hul, Erik, Woestenborghs, Heidi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224256/
https://ncbi.nlm.nih.gov/pubmed/25408662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368207
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!